ICAM-1 has been shown to initiate malignant invasion in a number of malignancies via its interaction with apical MUC-1 on circulating tumor cells and this interaction can be enhanced by tumor cytokine activities (Roland et al. 2007). This evidence concerns the gene MUC1 and neoplasm.